Cargando…

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults

OBJECTIVE: The Growth Hormone Research Society (GRS) convened a Workshop in 2017 to evaluate clinical endpoints, surrogate endpoints and biomarkers during GH treatment of children and adults and in patients with acromegaly. PARTICIPANTS: GRS invited 34 international experts including clinicians, bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johannsson, Gudmundur, Bidlingmaier, Martin, Biller, Beverly M K, Boguszewski, Margaret, Casanueva, Felipe F, Chanson, Philippe, Clayton, Peter E, Choong, Catherine S, Clemmons, David, Dattani, Mehul, Frystyk, Jan, Ho, Ken, Hoffman, Andrew R, Horikawa, Reiko, Juul, Anders, Kopchick, John J, Luo, Xiaoping, Neggers, Sebastian, Netchine, Irene, Olsson, Daniel S, Radovick, Sally, Rosenfeld, Ron, Ross, Richard J, Schilbach, Katharina, Solberg, Paulo, Strasburger, Christian, Trainer, Peter, Yuen, Kevin C J, Wickstrom, Kerstin, Jorgensen, Jens O L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868631/ https://www.ncbi.nlm.nih.gov/pubmed/29483159 http://dx.doi.org/10.1530/EC-18-0047

Ejemplares similares

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations
por: Christiansen, Jens Sandahl, et al.
Publicado: (2016)

GH deficiency and insensitivity in children and adults
por: Johannsson, Gudmundur, et al.
Publicado: (2021)

GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults
por: Allen, D B, et al.
Publicado: (2015)

Dose–exposure–IGF-I response of once-weekly somapacitan in adults with GH deficiency
por: Kildemoes, Rasmus Juul, et al.
Publicado: (2022)

A Consensus Statement on acromegaly therapeutic outcomes
por: Melmed, Shlomo, et al.
Publicado: (2018)

Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice
por: Boguszewski, Margaret C. S., et al.
Publicado: (2021)

Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?
por: Ho, Ken, et al.
Publicado: (2021)

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
por: Boguszewski, Margaret C S, et al.
Publicado: (2022)

Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN)
por: Eggermann, Thomas, et al.
Publicado: (2020)

Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation
por: Bidlingmaier, Martin, et al.
Publicado: (2022)

Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation
por: Bidlingmaier, Martin, et al.
Publicado: (2023)

The Use of IGF-I to Monitor Long-Acting Growth Hormone Therapy—Timing is an Art…
por: Bidlingmaier, Martin, et al.
Publicado: (2021)

Laboratory investigations in the diagnosis and follow-up of GH-related disorders
por: Schilbach, Katharina, et al.
Publicado: (2019)

Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly
por: Clemmons, David R., et al.
Publicado: (2023)

A consensus on the diagnosis and treatment of acromegaly complications
por: Melmed, S., et al.
Publicado: (2012)

Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults)
por: Höybye, Charlotte, et al.
Publicado: (2021)

SAT-LB074 Efficacy and Safety of Once-weekly Somapacitan in Adult Growth Hormone Deficiency (AGHD) Confirmed in a 53‑week Real 1 Trial Extension
por: Johannsson, Gudmundur, et al.
Publicado: (2019)

Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Subbarayan, Anbezhil, et al.
Publicado: (2014)

Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly
por: Strasburger, Christian J, et al.
Publicado: (2016)

Health Care Burden in Patients With Adrenal Insufficiency
por: Gunnarsson, Candace, et al.
Publicado: (2017)

Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case–Control Study
por: van Santen, Selveta S, et al.
Publicado: (2021)

Comprehensive genetic testing approaches as the basis for personalized management of growth disturbances: current status and perspectives
por: van der Kaay, Danielle Christine Maria, et al.
Publicado: (2022)

ENDO-ERN expert opinion on the differential diagnosis of pubertal delay
por: Persani, Luca, et al.
Publicado: (2021)

Editorial: Primary Adrenal Insufficiency - Quality of Life and Long-Term Outcome With Current Treatment Strategies
por: Esposito, Daniela, et al.
Publicado: (2022)

MON-096 Body Composition in Patients with Craniopharyngioma: Is DXA-Scanning Necessary for Evaluating the Metabolic Syndrome?
por: van Santen, Selveta, et al.
Publicado: (2019)

Can Growth Hormone Lead to a Faster Recovery from Guillain-Barré Syndrome? Case Report of the First Therapeutic Use in One Patient
por: Amereller, Felix, et al.
Publicado: (2023)

Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism: the patients‘ perspective
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2020)

Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency
por: Takahashi, Yutaka, et al.
Publicado: (2022)

Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial
por: Johannsson, Gudmundur, et al.
Publicado: (2020)

OR32-4 Diagnostic Performance of Macimorelin vs the Insulin Tolerance Test (ITT) in 140 Patients at Varying Growth Hormone (GH) Cutpoints: A Post Hoc Analysis
por: Garcia, Jose, et al.
Publicado: (2019)

Adults’ Adherence to Growth Hormone Replacement in Relation to Medication-Related Beliefs, Coping and Quality of Life - An Exploratory Analysis
por: Siegel, Sonja, et al.
Publicado: (2021)

Extracellular Water and Blood Pressure in Adults with Growth Hormone (GH) Deficiency: A Genotype-Phenotype Association Study
por: Barbosa, Edna J. L., et al.
Publicado: (2014)

THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe
por: Grossman, Ashley, et al.
Publicado: (2013)

MON-330 Cancer Incidence in 1,296 Patients with Acromegaly Is Not Increased: A Nationwide Population-Based Study
por: Esposito, Daniela, et al.
Publicado: (2020)

SAT-428 Effect of Age, Body Mass Index, and Sex on the Performance of Macimorelin for the Diagnosis of Adult Growth Hormone Deficiency: A Post Hoc Analysis
por: Garcia, Jose, et al.
Publicado: (2019)

The Future of Genomic Endocrinology
por: Dattani, Mehul T., et al.
Publicado: (2011)

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults
por: Strasburger, Christian J, et al.
Publicado: (2016)

SUN-336 Obesity and Impaired Glucose Metabolism in Adult Patients with X-Linked Hypophosphatemia
por: Lecoq, Anne-Lise, et al.
Publicado: (2020)

Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years
por: van Santen, Selveta S, et al.
Publicado: (2020)

New options for the medical treatment of Cushing's syndrome
por: Trainer, Peter J.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sl4gkp6gp76c4tsoot3uk0nqr3